Araştırma Makalesi
BibTex RIS Kaynak Göster

Dyke-Davidoff-Masson Sendromlu Olguların Değerlendirilmesi

Yıl 2021, , 50 - 55, 20.01.2021
https://doi.org/10.20515/otd.739781

Öz

Dyke-Davidoff-Masson Sendromu(DDMS) nadir görülen, temel olarak serebral hemiatrofi, karşı tarafta hemipleji/hemiparezi, epilepsi ve mental retardasyon ile karakterize bir hastalıktır. Etiyolojisine göre akut DDMS ve konjenital DDMS olarak ayrılır. Retrospektif olarak yapılan bu çalışmada çocuk nörolojisi kliniğinde DDMS tanısı ile takip edilen hastaların demografik, klinik ve radyolojik bulgularının sunulması amaçlanmıştır. Çalışmaya 7 erkek 3 kız olmak üzere 10 hasta dahil edildi. Hastaların yaş ortalaması 8.3±1.2 yıldı. Çalışmamızda 8 hasta konjenital DDMS, perinatal serebral iskemisi olan bir hasta ve merkezi sinir sistemi enfeksiyonu geçiren bir hasta olmak üzere toplam 2 hasta ise akut DDMS olarak kabul edildi. Yedi hastada sol, 3 hastada ise sağ serebral hemiatrofi vardı. Yedi hastada hemiatrofi tarafında ensefalomalazik değişiklikler ve 7 hastada hemiatrofi tarafında lateral ventrikül dilatasyonu saptandı. Tüm hastalarda epilepsi vardı ve 5’i dirençli epilepsi hastasıydı. Ortalama DDMS tanısı konulduğu yaş 7±1.08 yıl, ilk beyin görüntülemesi yapılan yaş ise 3.4±1.2 yıldı. Hastaların ilk beyin görüntüleme yaşları ile DDMS olarak tanı konuldukları yaş arasında yaklaşık 2 kat fark var olması, DDMS’ nin bilinirliğinin yeterli olmadığını düşündürmektedir. Hemipleji/hemiparezi, epilepsi ve mental retardasyonu olan, beyin görüntülemesinde hemiatrofi saptanan hastalarda DDMS mutlaka ön tanılar arasında yer almalıdır.

Kaynakça

  • 1. Chand G, Goel R, Kapur R. Dyke-Davidoff-Masson Syndrome. Arch Neurol. 2010;67(8):1026.
  • 2. Atalar MH, Icagasıoglu D, Tas F. Cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome) in childhood: clinicoradiological analysis of 19 cases. Pediatric Internationa.l 2007;49(1): 70-5.
  • 3. Singh P, Saggar K, Ahluwalia A. Dyke–Davidoff–Masson syndrome: classical imaging findings. J Pediatr Neurosci. 2010;5(2):124-5.
  • 4. Dyke CG, Davidoff LM, Masson CB. Cerebral hemiatrophy and homolateral hypertrophy of the skull and sinuses. Surg Gynecol Obstet. 1933;57:588-600
  • 5. Roy U, Panwar A, Mukherjee A, Biswas D. Adult presentation of dykeDavidoff-Masson syndrome: a case report. Case Rep Neurol. 2016;8(1):20-6.
  • 6. Dix JE, Cail WS. Cerebral hemiatrophy: classification on the basis of MR imaging findings of mesial sclerosis and childhood febrile seizures . Radiology. 1997;203(1):269-74.
  • 7. Yorulmaz I, Kalaycioglu S, Orguc S, et al. CT and MR imaging of cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome) cases . Turk. J. Diagn. Interv. Radiol. 1993;3:63-8.
  • 8. Tasdemir HA, Incesu L, Yazicioglu AK, et al. DykeDavidoff-Masson syndrome. Clin. Imaging. 2002;26(1):13-7.
  • 9. Gökçe E, Beyhan M, Sade R. Radiological imaging findings of Dyke-Davidoff-Masson syndrome. Acta Neurol Belg. 2017;117(4):885-893.
  • 10. Arora R, Rani JY. Dyke–Davidoff–Masson syndrome: imaging features with illustration of two cases. Quant Imaging Med Surg. 2015;5(3):469-71.
  • 11. Aguiar PH, Liu CW, Leitao H, et al. MR and CT imaging in the Dyke-Davidoff-Masson syndrome: report of three cases and contribution to pathogenesis and differential diagnosis. Arq Neuropsiquatr. 1998;56(4):803-7
  • 12. Zeiss J, Brinker RA. MR imaging of cerebral hemiatrophy. J. Comput. Assist. Tomogr. 1988; 12(4): 640-3 .
  • 13. Behera MR, Patnaik S, Mohanty AK. Dyke-Davidoff-Masson syndrome. J Neurosci Rural Pract. 2012;3(3):411-3.
  • 14. Unal O, Tombul T, Cırak B, et al. Left hemisphere and sex dominance of cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome). Clin Imaging. 2004;28(3):163-5.
  • 15. Hsin yl, Chuang MF, Shen TW, et al. Temporospatial analysis define epileptogenic and functional zone in a case of DDMS. Seizure. 2011;20(9):713-16.
  • 16. Thomas-Sohl KA, Vaslow DF, Maria BL. Sturge–Weber syndrome: a review. Pediatr Neurol. 2004;30(5):303-10
  • 17. Sheybani L, Schaller K, Seeck M. Rasmussen encephalitis: an update. Schweiz Arch Neurol. Psychiatr. 2011;162(6):225-31
  • 18. Kocak O, Yarar C, Carman KB. Encephalocraniocutaneous lipomatosis, a rare neurocutaneous disorder: report of additional three cases. Childs Nerv Syst. 2016;32(3):559-62
  • 19. Wakeling EL, Amero SA, Alders M, et al. Epigenotype-phenotype correlations in Silver-Russell syndrome. J Med Genet. 2010; 47(11): 760-8.

Evaluation of Patients with Dyke-Davidoff-Masson Syndrome

Yıl 2021, , 50 - 55, 20.01.2021
https://doi.org/10.20515/otd.739781

Öz

Dyke-Davidoff-Masson syndrome (DDMS) is characterized by cerebral hemiatrophy, contralateral hemiplegia/hemiparesis, epilepsy and mental retardation. The purpose of this retrospective study was to emphasize the demographic, clinical and imaging findings of 10 child (7 boys, 3 girls) with DDMS. The mean age of the patients was 8.3 ± 1.2 years. Eight of our patients were considered as congenital DDMS. The remaining 2 patients were considered as congenital DDMS. In these patients, symptoms appeared following postnatal hypoxic ischaemia and central nervous system infection. Seven patients had left and 3 patients had right cerebral hemiatrophy. Ipsilateral lateral ventricular dilatation and encephalomalacia were observed in 7 patients. All patients had unilateral hemiparesis / hemiplegia and mental/motor retardation. Five patients had resistant epilepsy. The mean age for the diagnosis of DDMS was 7 ± 1.08 years, and the initial brain imaging age was 3.4 ± 1.2 years. There were approximately two times the difference between the first brain imaging ages of patients and the age at which they were diagnosed as DDMS. This suggests that the awareness of DDMS is not sufficient. DDMS should be among the preliminary diagnoses in patients with hemiplegia / hemiparesis, epilepsy, and mental retardation and with hemiatrophy in brain imaging.

Kaynakça

  • 1. Chand G, Goel R, Kapur R. Dyke-Davidoff-Masson Syndrome. Arch Neurol. 2010;67(8):1026.
  • 2. Atalar MH, Icagasıoglu D, Tas F. Cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome) in childhood: clinicoradiological analysis of 19 cases. Pediatric Internationa.l 2007;49(1): 70-5.
  • 3. Singh P, Saggar K, Ahluwalia A. Dyke–Davidoff–Masson syndrome: classical imaging findings. J Pediatr Neurosci. 2010;5(2):124-5.
  • 4. Dyke CG, Davidoff LM, Masson CB. Cerebral hemiatrophy and homolateral hypertrophy of the skull and sinuses. Surg Gynecol Obstet. 1933;57:588-600
  • 5. Roy U, Panwar A, Mukherjee A, Biswas D. Adult presentation of dykeDavidoff-Masson syndrome: a case report. Case Rep Neurol. 2016;8(1):20-6.
  • 6. Dix JE, Cail WS. Cerebral hemiatrophy: classification on the basis of MR imaging findings of mesial sclerosis and childhood febrile seizures . Radiology. 1997;203(1):269-74.
  • 7. Yorulmaz I, Kalaycioglu S, Orguc S, et al. CT and MR imaging of cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome) cases . Turk. J. Diagn. Interv. Radiol. 1993;3:63-8.
  • 8. Tasdemir HA, Incesu L, Yazicioglu AK, et al. DykeDavidoff-Masson syndrome. Clin. Imaging. 2002;26(1):13-7.
  • 9. Gökçe E, Beyhan M, Sade R. Radiological imaging findings of Dyke-Davidoff-Masson syndrome. Acta Neurol Belg. 2017;117(4):885-893.
  • 10. Arora R, Rani JY. Dyke–Davidoff–Masson syndrome: imaging features with illustration of two cases. Quant Imaging Med Surg. 2015;5(3):469-71.
  • 11. Aguiar PH, Liu CW, Leitao H, et al. MR and CT imaging in the Dyke-Davidoff-Masson syndrome: report of three cases and contribution to pathogenesis and differential diagnosis. Arq Neuropsiquatr. 1998;56(4):803-7
  • 12. Zeiss J, Brinker RA. MR imaging of cerebral hemiatrophy. J. Comput. Assist. Tomogr. 1988; 12(4): 640-3 .
  • 13. Behera MR, Patnaik S, Mohanty AK. Dyke-Davidoff-Masson syndrome. J Neurosci Rural Pract. 2012;3(3):411-3.
  • 14. Unal O, Tombul T, Cırak B, et al. Left hemisphere and sex dominance of cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome). Clin Imaging. 2004;28(3):163-5.
  • 15. Hsin yl, Chuang MF, Shen TW, et al. Temporospatial analysis define epileptogenic and functional zone in a case of DDMS. Seizure. 2011;20(9):713-16.
  • 16. Thomas-Sohl KA, Vaslow DF, Maria BL. Sturge–Weber syndrome: a review. Pediatr Neurol. 2004;30(5):303-10
  • 17. Sheybani L, Schaller K, Seeck M. Rasmussen encephalitis: an update. Schweiz Arch Neurol. Psychiatr. 2011;162(6):225-31
  • 18. Kocak O, Yarar C, Carman KB. Encephalocraniocutaneous lipomatosis, a rare neurocutaneous disorder: report of additional three cases. Childs Nerv Syst. 2016;32(3):559-62
  • 19. Wakeling EL, Amero SA, Alders M, et al. Epigenotype-phenotype correlations in Silver-Russell syndrome. J Med Genet. 2010; 47(11): 760-8.
Toplam 19 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Sağlık Kurumları Yönetimi
Bölüm ORİJİNAL MAKALELER / ORIGINAL ARTICLES
Yazarlar

Ozan Koçak 0000-0002-2285-7983

Yayımlanma Tarihi 20 Ocak 2021
Yayımlandığı Sayı Yıl 2021

Kaynak Göster

Vancouver Koçak O. Dyke-Davidoff-Masson Sendromlu Olguların Değerlendirilmesi. Osmangazi Tıp Dergisi. 2021;43(1):50-5.


13299        13308       13306       13305    13307  1330126978